Annual EBITDA
-$54.04 M
-$26.70 M-97.69%
December 31, 2022
Summary
- As of February 10, 2025, THRX annual EBITDA is -$54.04 million, with the most recent change of -$26.70 million (-97.69%) on December 31, 2022.
- During the last 3 years, THRX annual EBITDA has fallen by -$49.10 million (-993.85%).
Performance
THRX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBITDA
-$16.38 M
+$1.19 M+6.75%
September 30, 2023
Summary
- As of February 10, 2025, THRX quarterly EBITDA is -$16.38 million, with the most recent change of +$1.19 million (+6.75%) on September 30, 2023.
- Over the past year, THRX quarterly EBITDA has dropped by -$451.00 thousand (-2.83%).
Performance
THRX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBITDA
-$66.44 M
-$451.00 K-0.68%
September 30, 2023
Summary
- As of February 10, 2025, THRX TTM EBITDA is -$66.44 million, with the most recent change of -$451.00 thousand (-0.68%) on September 30, 2023.
- Over the past year, THRX TTM EBITDA has dropped by -$19.21 million (-40.66%).
Performance
THRX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
THRX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -97.7% | -2.8% | -40.7% |
| 3 y3 years | -993.9% | -1047.1% | -4552.7% |
| 5 y5 years | -993.9% | -1047.1% | -4552.7% |
THRX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | +97.7% | at low | +89.2% | +7.2% | +143.1% | at low |
| 5 y | 5-year | +993.8% | at low | +1047.1% | +7.2% | +4552.7% | at low |
| alltime | all time | +993.8% | at low | +1047.1% | +7.2% | +4552.7% | at low |
Theseus Pharmaceuticals EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | -$16.38 M(-6.7%) | -$66.44 M(+0.7%) |
| Jun 2023 | - | -$17.57 M(+3.1%) | -$65.99 M(+9.1%) |
| Mar 2023 | - | -$17.04 M(+10.2%) | -$60.49 M(+11.9%) |
| Dec 2022 | -$54.04 M(+97.7%) | -$15.46 M(-3.0%) | -$54.04 M(+14.4%) |
| Sep 2022 | - | -$15.93 M(+32.0%) | -$47.23 M(+22.1%) |
| Jun 2022 | - | -$12.07 M(+14.1%) | -$38.68 M(+15.7%) |
| Mar 2022 | - | -$10.58 M(+22.2%) | -$33.42 M(+22.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$27.33 M(+300.0%) | -$8.66 M(+17.4%) | -$27.33 M(+26.8%) |
| Sep 2021 | - | -$7.37 M(+8.2%) | -$21.56 M(+38.1%) |
| Jun 2021 | - | -$6.81 M(+51.8%) | -$15.62 M(+77.4%) |
| Mar 2021 | - | -$4.49 M(+55.4%) | -$8.80 M(+104.0%) |
| Dec 2020 | -$6.83 M(+38.3%) | -$2.89 M(+102.2%) | -$4.32 M(+202.2%) |
| Sep 2020 | - | -$1.43 M | -$1.43 M |
| Dec 2019 | -$4.94 M | - | - |
FAQ
- What is Theseus Pharmaceuticals annual EBITDA?
- What is the all time high annual EBITDA for Theseus Pharmaceuticals?
- What is Theseus Pharmaceuticals annual EBITDA year-on-year change?
- What is Theseus Pharmaceuticals quarterly EBITDA?
- What is the all time high quarterly EBITDA for Theseus Pharmaceuticals?
- What is Theseus Pharmaceuticals quarterly EBITDA year-on-year change?
- What is Theseus Pharmaceuticals TTM EBITDA?
- What is the all time high TTM EBITDA for Theseus Pharmaceuticals?
- What is Theseus Pharmaceuticals TTM EBITDA year-on-year change?
What is Theseus Pharmaceuticals annual EBITDA?
The current annual EBITDA of THRX is -$54.04 M
What is the all time high annual EBITDA for Theseus Pharmaceuticals?
Theseus Pharmaceuticals all-time high annual EBITDA is -$4.94 M
What is Theseus Pharmaceuticals annual EBITDA year-on-year change?
Over the past year, THRX annual EBITDA has changed by -$26.70 M (-97.69%)
What is Theseus Pharmaceuticals quarterly EBITDA?
The current quarterly EBITDA of THRX is -$16.38 M
What is the all time high quarterly EBITDA for Theseus Pharmaceuticals?
Theseus Pharmaceuticals all-time high quarterly EBITDA is -$1.43 M
What is Theseus Pharmaceuticals quarterly EBITDA year-on-year change?
Over the past year, THRX quarterly EBITDA has changed by -$451.00 K (-2.83%)
What is Theseus Pharmaceuticals TTM EBITDA?
The current TTM EBITDA of THRX is -$66.44 M
What is the all time high TTM EBITDA for Theseus Pharmaceuticals?
Theseus Pharmaceuticals all-time high TTM EBITDA is -$1.43 M
What is Theseus Pharmaceuticals TTM EBITDA year-on-year change?
Over the past year, THRX TTM EBITDA has changed by -$19.21 M (-40.66%)